Skip to main content
. 2014 Mar 29;166(1):98–108. doi: 10.1111/bjh.12854

Table 1.

Patient characteristics of the MCL2/3 cohort.

Parameter n (%)
Male 83 (74)
Stage IV 95 (85)
MIPIlow 60 (54)
MIPIintermediate 28 (25)
MIPIhigh 23 (21)
Blastoid variant of MCL 26 (23)
Common variant of MCL 86 (77)
TP53weak 78 (70)
TP53intermediate 5 (4)
TP53strong 10 (9)
TP53not available 19 (17)
MKI67 (0–9%) 12 (11)
MKI67 (10–29%) 47 (42)
MKI67 (30–100%) 38 (34)
MKI67 (not available) 15 (13)